天骄生物由80后董事长张钊夫妇控股84%，妻子赵彤退出董事会

Core Viewpoint - Shandong Tianjiao Biotechnology Co., Ltd. (Tianjiao Bio) has completed its IPO counseling record with the Shandong Securities Regulatory Bureau and plans to list on the A-share market, with Guotai Junan Securities Co., Ltd. as the counseling institution [1]. Company Overview - Tianjiao Bio was established on December 18, 2004, with a registered capital of 51.033887 million yuan, primarily engaged in the research, production, and sales of powdered oils, plant-based products, starch sugars, and other solid beverages [2]. - The company is controlled by Zhang Zhao and Zhao Tong, who hold 84.35% of the voting rights through Tianjiu Group and employee stock ownership platforms [2]. Financial Performance - The projected operating revenues for Tianjiao Bio are 1.154 billion yuan for 2023, 1.275 billion yuan for 2024, and 580 million yuan for the first half of 2025. The net profits are expected to be 109 million yuan, 144 million yuan, and 54.36 million yuan for the same periods, respectively [2]. Management Background - Zhang Zhao, aged 42, has held various positions including auditor, deputy general manager, and chairman of Tianjiao Bio since November 2013 [3]. - Zhao Tong, also aged 42, has experience in management roles within the company and has been involved in various capacities since 2009 [4].